Intended for healthcare professionals


Seven days in medicine: 2-8 June 2021

BMJ 2021; 373 doi: (Published 10 June 2021) Cite this as: BMJ 2021;373:n1455


Antibodies “cut reinfections” in care homes

A study of 682 residents and 1429 members of staff at 97 long term care facilities in England indicated that having antibodies to SARS-CoV-2 substantially reduced the risk of reinfection in staff and residents for as long as 10 months after primary infection. Reported in the Lancet Healthy Longevity,1 the study showed that 33% of residents and 29% of staff had antibodies at baseline. Previous infection was linked to a reduction in risk of subsequent infection by 85% among residents and by 60% among staff.

Long covid affects at least a million in UK

An estimated one million people in the UK (1.6%) were experiencing self-reported symptoms of “long” covid (symptoms persisting for more than four weeks after initial infection) up to 2 May, said an analysis by the Office for National Statistics.2 The self-reported symptoms were affecting the ability of 650 000 people to perform day-to-day activities, and 192 000 said that they were limited a lot. Fatigue was the most common symptom reported, followed by shortness of breath, muscle ache, and difficulty concentrating.


Pfizer vaccine is safe for 12-15 year olds—MHRA

The Joint Committee on Vaccination and Immunisation will have to advise on whether 12-15 year olds should be …

View Full Text

Log in

Log in through your institution


* For online subscription